Esperion Therapeutics, Inc. (FRA:0ET)
2.654
+0.141 (5.61%)
At close: Jan 23, 2026
Esperion Therapeutics Market Cap
Esperion Therapeutics has a market cap or net worth of €671.77 million as of January 30, 2026. Its market cap has increased by 58.73% in one year.
Market Cap
671.77M
Enterprise Value
1.10B
Revenue
258.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.65
Market Cap Chart
Since June 26, 2013, Esperion Therapeutics's market cap has increased from 162.73M to 671.77M, an increase of 312.82%. That is a compound annual growth rate of 11.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 671.77M | -9.45% |
| Dec 31, 2025 | 741.91M | 77.20% |
| Dec 31, 2024 | 418.70M | 36.11% |
| Dec 29, 2023 | 307.61M | -28.38% |
| Dec 30, 2022 | 429.53M | 59.59% |
| Dec 31, 2021 | 269.15M | -54.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sedlmayr Grund und Immobilien AG | 983.95M |
| Berliner Effektengesellschaft AG | 886.48M |
| Northern Data AG | 815.94M |
| Maschinenfabrik Berthold Hermle AG | 787.50M |
| Paul Hartmann AG | 777.83M |
| EUROKAI GmbH & Co. KGaA | 688.26M |
| FRoSTA Aktiengesellschaft | 656.73M |
| Südwestdeutsche Salzwerke AG | 640.96M |